Clinical trial
The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)
NCT00267670 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)
- Lead sponsor
- Northwestern University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- September 30, 2009
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver diseases, nonalcoholic steatohepatitis